Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
R-3750 is an oral synthetic biology-based cellular immunotherapy developed by Rise Therapeutics for the treatment of Inflammatory Bowel Disease (IBD), specifically targeting ulcerative colitis. It is designed to reduce gut inflammation, improve intestinal barrier integrity, and restore a more normal microbiome composition. R-3750 leverages Rise Therapeutics' proprietary drug delivery platform to deliver targeted biological therapy orally, engaging dendritic cells in the gut to reduce inflammation and improve disease outcomes
R-3750 is a SlpA-expressing [Lactococcus lactis](brain://Y…